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 7 
Protists embrace many species, some of which may be either occasional or permanent 8 
parasites of vertebrate animals. Between the parasite species, several of medical and 9 
veterinary importance are vector-transmitted. The ecology and epidemiology of vector- 10 
borne parasitoses, including babesiosis, leishmaniasis and malaria, are particularly 11 
complex, as they are influenced by many factors, such as vector reproductive efficiency 12 
and geographical spread, vectorial capacity, host immunity, travel and human 13 
behaviour and climatic factors. Transmission dynamics are determined by the 14 
interactions between pathogen, vector, host and environmental factors and, given their 15 
complexity, many different types of mathematical models have been developed to 16 
understand them. A good basic knowledge of vector-pathogen relationships and 17 
transmission dynamics is thus essential for disease surveillance and control 18 
interventions and may help in understanding the spread of epidemics and be useful for 19 
public health planning.  20 
 21 
1. Babesiosis and Babesia spp. of Domestic Dogs – Where do they Fit in the 22 
Piroplasmid World? 23 
Babesia are tick-borne protozoan parasites from the phylum Apicomplexa, class 24 
Piroplasmea and order Piroplasmida which infect erythrocytes of animals and humans. 25 
The main clinical manifestations of babesiosis in animals and humans are associated 26 
with hemolysis, anemia, tissue anoxia, hemolytic toxins and inflammatory mediators 27 
produced during infection (Irwin, 2009; Lempereur et al., 2017). Babesiosis is a 28 
medically important tick-borne disease of humans in several areas of the world and it 29 
also has a major economic impact to livestock and agriculture (Lempereur et al., 2017; 30 
Wagner et al., 2019). Babesia spp. are an important threat in human and veterinary 31 
medicine as they are transmitted via blood transfusion from donors to recipients 32 
(Wagner et al., 2019; Wardrop et al., 2016). The genera Babesia, Theileria and 33 
Cytauxzoon are genetically related to each other and are referred to collectively as 34 
piroplasmids. Parasites belonging to these three genera infect erythrocytes, however, 35 
while the Theileria and Cytauxzoon have schizont stages that infect other types of cells, 36 
Babesia spp. infect only erythrocytes. There is currently a motion to reorganize 37 
parasites belonging to the Piroplasmida into several genetically distinct clades and 38 
possible future different genera dividing also the Babesia into more than one genus 39 
(Jalovecka et al., 2019). The currently known Babesia spp. which infect dogs are a good 40 
example of a group of parasites that often have similar characteristics, however they 41 
differ genetically and are likely to be assigned to different and diverging genera in the 42 
future (Baneth, 2011; Irwin, 2009; Solano-Gallego and Baneth, 2011). 43 
The canine babesiae are divided into several lineages as assessed by 18S RNA gene 44 
phylogeny (Jalovecka et al., 2019). The babesial spp. that infect dogs can also be 45 
separated into those that present with a large merozoite stage in erythrocytes 46 
(approximately 5 x 2 µm), termed “large” canine Babesia, which belong to the Babesia 47 
sensu stricto and those which have distinctly smaller merozoites (approximately 0.3 x 48 
3 µm) termed “small” and classified mostly as Babesia sensu lato (Baneth, 2011, 2018; 49 
Jalovecka et al., 2019; Solano-Gallego and Baneth, 2011). The clinical manifestations 50 
of canine babesiosis are mainly dependant on the infecting species and host-related 51 
factors. Babesia rossi, B. canis and B. vogeli have large merozoites and are identical 52 
morphologically but differ in the severity of clinical manifestations which they cause, 53 
their tick vectors, genetic characteristics, and geographic distributions (Baneth, 2011, 54 
2018; Irwin, 2009; Solano-Gallego and Baneth, 2011). Another yet unnamed large 55 
Babesia sp. most closely related to B. bigemina of cattle infects immunocompromised 56 
dogs in North America (Sikorski et al., 2010). The small Babesia spp. that infect dogs 57 
include B. gibsoni, B. conradae described from California, B. vulpes which primarily 58 
infects foxes and B. negevi described from Israel (Baneth, 2011, 2018; Baneth et al., 59 
2020; Irwin, 2009; Solano-Gallego and Baneth, 2011). None of the Babesia spp. that 60 
infect dogs is known to be zoonotic. Although the transmission of canine babesiae 61 
occurs through the bite of a vector tick, infection has also been demonstrated to be 62 
transmitted via blood transfusion and transplacentally for some species (Baneth, 2011; 63 
Irwin, 2009; Solano-Gallego and Baneth, 2011; Wardrop et al., 2016). Furthermore, 64 
several studies have provided evidence that B. gibsoni is likely transmitted directly from 65 
dog to dog via bite wounds, saliva, or ingested blood (Birkenheuer et al., 2005; Jefferies 66 
et al., 2007). As Babesia spp. are transmitted by blood product transfusions, it is 67 
recommended to screen canine blood donors for infection (Wardrop et al., 2016). Non- 68 
vectorial dog to dog transmission of different Babesia spp. by fighting and blood 69 
transfusion can be responsible for the spread of babesiosis into non-endemic areas 70 
where their tick vectors are not present. The differences between Babesia spp. that 71 
infect dogs are also reflected in their susceptibility to drugs and therefore accurate 72 
detection and species recognition are important for the selection of the correct therapy 73 
and predicting the course of disease. While large Babesia spp. are usually susceptible 74 
to certain drugs such as imidcorab dipropionate and diminazene aceturate, small 75 
Babesia spp. are often resistant and treatment requires the use of other drugs and their 76 
combinations such as atovaquone with azithromycin (Baneth, 2018).  77 
In conclusion, the variety of Babesia spp. which infect dogs represent a microcosm of 78 
the total variety of species which infect wildlife, domestic animals and humans. The 79 
similarities and differences between the diseases caused by these agents and the 80 
precautions taken to prevent transmission of babesiosis by blood transfusion in dogs 81 
are also applicable to human medicine where the same problem occurs.  82 
 83 
2. New Leishmania Parasites and New Vectors. 84 
Leishmania are protozoan parasites that are transmitted by the bites of phlebotomine 85 
sand flies, small blood-feeding dipteran insects (Bates, 2007). In their vertebrate hosts 86 
Leishmania live as intracellular parasites inside various cells, typically macrophages, 87 
residing within phagolysosomes as amastigote life-cycle stages. Female sand flies, 88 
when seeking a blood meal, will cause damage to the skin of the vertebrate host, causing 89 
the release of infected cells containing amastigotes into the wound, which are then taken 90 
up with the blood meal. In the midgut of the sand fly amastigotes transform into 91 
promastigotes, elongated and motile forms that go through various life-cycle stages to 92 
complete their development in the vector (Bates, 2018). The final stage in the sand fly 93 
host are the metacyclic promastigotes, infective forms that are transmitted by bite when 94 
the sand fly takes another blood meal. 95 
Over 30 species of Leishmania have been described, and of these 11 are of major 96 
biomedical importance: L. donovani and L. infantum, which cause visceral 97 
leishmaniasis; L. major, L. tropica and L. aethiopica, which cause cutaneous 98 
leishmaniasis in Europe, African and Asia; L. mexicana, L. amazonensis, L. 99 
panamensis, L. guyanensis and L. peruviana, which cause cutaneous leishmaniasis in 100 
Central and South America; and L. braziliensis, which cause cutaneous and 101 
mucocutaneous leishmaniasis in Central and South America (Alvar et al., 2012). These 102 
11 species cause the majority of the symptomatic human cases of leishmaniasis in the 103 
world and, therefore, have been the most intensively studied to date.  104 
Leishmania spp. can infect a wide variety of vertebrate hosts depending on the 105 
particular species of parasite, and these hosts can include various mammals such as 106 
domestic and wild canines (Dusicyon thous, Vulpes vulpes), rodents (Ototylomys 107 
phyllotis, Proechimys guyanensis, Psammomys obesus, Rhombomys opimus), hyraxes 108 
(Heterohyrax brucei, Procavia capensis), sloths (Choloepus didactylus, C. hoffmani), 109 
opossums (Didelphis marsupialis) and anteaters (Tamandua tetradactyla), as well 110 
various lizards (Ashford, 2000). Some of these are dead end hosts, but others are true 111 
intermediate hosts acting as a potential source of parasites for feeding sand flies and 112 
continuing the life-cycle. Similarly there are many different species of sand fly involved 113 
in the transmission of leishmaniasis, with approximately 70 identified as vectors 114 
(Maroli et al., 2013). There are specific associations between vectors and the parasites 115 
they transmit, such that each parasite is transmitted by a small number of vector species, 116 
but each vector can only transmit one species of parasite. Transmission occurs in a wide 117 
variety of environments around the world including semi-arid through to tropical 118 
rainforest environments, and of increasing concern also in urban environments. 119 
Leishmania spp. have, until recently, been placed into one of three subgenera: 120 
Leishmania, Viannia and Sauroleishmania. However, recent work has provided 121 
evidence for a new phylogenetic grouping of Leishmania parasites, placed in the new 122 
subgenus Mundinia (Espinosa et al., 2018). Species in the Mundinia include L. enriettii 123 
from guinea pigs, Cavia porcellus, in Brazil; (Lainson, 1997), L. martiniquensis from 124 
humans in Martinique, but now known to have a wider distribution; (Pothirat et al., 125 
2014), L. macropodum from kangaroos in Australia; (Rose et al., 2004), L. orientalis 126 
from humans in Thailand; (Jariyapan et al., 2018), and two as yet unnamed Leishmania 127 
species from Ghana and Namibia. Some of these parasites are known human pathogens, 128 
whilst others appear to be confined to wild animals. The very wide geographical spread 129 
of the Mundinia, wider than any of the other subgenera, together with their branching 130 
from the base of the Leishmania phylogenetic tree, both suggest an early branching and 131 
ancient lineage (Pothirat et al., 2014). The insect vectors of the Mundinia have not been 132 
established with certainty for any member.  133 
L. enriettii is the best known of these species, first isolated in 1948 (Lainson, 1997). It 134 
has been found only in domestic guinea pigs in Curitiba and Sao Paulo, but assumed to 135 
occur in related wild rodents. L. enriettii causes cutaneous leishmaniasis in guinea pigs, 136 
but it is not pathogenic to humans. L. martiniquensis has been isolated from humans in 137 
Martinique and Thailand, but with evidence that it also occurs in both Europe and the 138 
USA in horses and cattle (Pothirat et al., 2014). In both of these human foci the majority 139 
of cases present as disseminated or visceral leishmaniasis in immunocompromised 140 
(HIV-infected) patients. L. orientalis from Thailand causes cutaneous leishmaniasis, 141 
but again can occur as disseminated or visceral forms in HIV-infected individuals 142 
(Jariyapan et al., 2018). The currently un-named Leishmania from Ghana causes typical 143 
cutaneous leishmaniasis in humans living in the Volta region, the infections are usually 144 
self-healing but can leave unsightly scars (Kwakye-Nuako et al., 2015). The 145 
Leishmania from Namibia were originally isolated in the 1970s by Grové and 146 
colleagues. DNA sequencing showed that the human and sand fly Namibian isolates 147 
were L. tropica, but an isolate from a rock hyrax is another member of the Mundinia 148 
(Bates, unpublished data). L. macropodum has been found in a variety of marsupials in 149 
northern Australia, causing cutaneous leishmaniasis in these animals, but does not 150 
appear to be pathogenic in humans. This Mundinia species is the only one for which 151 
there is field evidence of the vector identity to date, and interestingly, the evidence to 152 
date supports the vectors of L. macropodum to be day-biting midges of the genus 153 
Forcipmyia (Dougall et al., 2011). However, this is not conclusive evidence as 154 
transmission by midge-bite has not been demonstrated. 155 
So far other efforts to identify the vectors of Mundinia in the field have proved 156 
inconclusive. However, various laboratory investigations have been performed using 157 
model vectors. For example, L. enriettii is unable to establish mature infections in 158 
Lutzomyia longipalpis, a widely used permissive sand fly host. However, Leishmania 159 
from Ghana, Thailand and L. enriettii are all able to develop better in experimental 160 
midge vectors (Culicoides) than in Lu. longipalpis under laboratory conditions, 161 
supporting that the midges might be vectors (Chanmol et al., 2019; Seblova et al., 162 
2015). On the other hand some species of Sergentomyia sand flies have been found 163 
PCR-positive in Ghana and Thailand. Therefore, although there is still uncertainty 164 
around the vectors for Mundinia species, the current evidence indicates the Leishmania 165 
(Mundinia) have non-conventional vectors. Their vectors appear unlikely to be 166 
Lutzomyia or Phlebotomus spp., the usual vectors. Further, it appears that some of the 167 
Leishmania (Mundinia) may even have non-sand fly vectors. This remains to be proven 168 
or disproven, however, if true, this would require a re-definition of the genus 169 
Leishmania to include non-sand fly transmission or the creation of a new genus to 170 
accomodate the non-sand fly transmitted parasites. 171 
In conclusion, the discovery of a new group of Leishmania species, now placed in the 172 
subgenus Mundinia, was something of a surprise. The number of clinical cases remains 173 
small in comparison to the 11 well known species listed above. However, in addition 174 
to their intrinsic biological interest there are important reasons to study these species 175 
from public health and biomedical perspectives. First, it is clear that in HIV- 176 
immunocompromised individuals they can cause serious and fatal infections. Second, 177 
it is likely that there is potentially widespread subclinical infection with these species 178 
in humans, which could have either beneficial or detrimental effects if a subsequent 179 
infection with a more pathogenic species occurs. Finally, the Mundinia present a good 180 
opportunity to use comparative genomics to explore the basis of pathogenicity, as the 181 
group contains species that are pathogenic and non-pathogenic to humans (Butenko et 182 
al., 2019). 183 
 184 
3. Plasmodium development in the mosquito midgut. A molecular and cellular 185 
view. 186 
Malaria is a devastating disease caused by unicellular protozoa, belonging to the genus 187 
Plasmodium. In 2018, WHO reported 220 million malaria cases globally and 405 188 
thousand lethal outcomes, mainly in children under 5 years of age (WHO, 2018). Even 189 
though between years 2000 and 2015, the global number of malaria cases significantly 190 
decreased and the number of malaria deaths had a decline of 60%, no significant 191 
progress in reducing global malaria cases was made for the period 2015–2018. This is 192 
due to several factors, such as low efficiency of the available malaria vaccine, spread 193 
of insecticide resistant mosquito vectors and drug resistant parasite strains, and 194 
inadequate monitoring of asymptomatic cases. Some high-burden countries even 195 
reported an increase in the number of cases between 2016 and 2017: of these, Nigeria, 196 
Madagascar and the Democratic Republic of the Congo had an estimated increase 197 
greater than half a million cases (WHO, 2018). One of the main cause of this surge is 198 
that malaria is concentrated in countries with the least resourced health systems. 199 
Democratic Republic of the Congo and Nigeria, both between the lowest income 200 
countries in Africa, together account for more than 35% of the total malaria deaths 201 
(WHO, 2018). 202 
It is now established that malaria long-term elimination cannot be achieved without 203 
controlling parasite transmission to mosquitoes and that we cannot rely only on vector 204 
control (Baird, 2019; Cohen et al., 2012). The discovery of new drugs to block malaria 205 
transmission is considered essential in the fight against the disease. In addition, drugs 206 
targeting transmission have the dual advantage of lowering parasite transmission and 207 
preventing the spread of drug-resistant parasites (Lu et al., 2018).  208 
Plasmodium asexual stages are responsible for the clinical manifestations of the 209 
disease, while the sexual stages, called gametocytes, are essential for parasite 210 
transmission to the mosquito vector. Malaria transmission is highly efficient: 211 
individuals with very low gametocyte densities, even undetectable by microscopy, can 212 
be infectious to mosquitoes (Bousema and Drakeley, 2011; Schneider et al., 2007). 213 
Monitoring individuals able to transmit the disease is thus difficult, in particular in 214 
countries where molecular diagnostic methods are not available. Malaria transmission 215 
dynamics are difficult to predict, since they are affected by many factors, such as 216 
climate (temperature, humidity and rainfalls), parasite and mosquito strains present in 217 
an area and different susceptibility to infection of human populations. Moreover, most 218 
of the available antimalarial drugs do not kill mature transmission stages and rather 219 
increase gametocyte production (Adjalley et al., 2011; Bousema and Drakeley, 2011; 220 
Plouffe et al., 2016). This, together with the fact that treated patients remain infectious 221 
for weeks after clinical symptoms disappearance (Bousema and Drakeley, 2011), 222 
makes malaria transmission control difficult to achieve.  223 
When ingested by mosquitoes, parasites differentiate into gametes and egress from the 224 
host cell to mate and form a zygote. During this whole process, parasites will have to 225 
survive outside the host cell in the mosquito midgut lumen for about 24 hours and 226 
defend themselves against the human immune system, the microbial flora and innate 227 
immune system of the insect. This exposure leads to an approximate 300‐fold loss of 228 
parasite abundance, representing a bottleneck in the parasite life cycle (Smith et al., 229 
2014). In this context, even a slight reduction in efficiency may dramatically affect 230 
parasite survival. The midgut stages are thus viewed as prime targets for transmission- 231 
blocking interventions. For mating to occur, gametes must egress from the host cell. 232 
This process takes place by successive inside-out rupture of the two membranes 233 
surrounding the parasite, the parasitophorous vacuole membrane and the host cell 234 
membrane (Andreadaki et al., 2018). A few minutes before egressing, some parasite 235 
secretory organelles, the osmiophilic bodies (OBs), migrate to the cell periphery and 236 
release their content in the parasitophorous vacuole lumen (Olivieri et al., 2015). We 237 
studied these secretory organelles involved in egress and contributed to their 238 
characterization in previous studies on Plasmodium berghei gametocytes. In male 239 
gemetocytes, OBs are club-shaped vesicles, smaller than the oval-shaped female OBs. 240 
We named these vescicles male osmiophilic bodies (MOBs). Upon gametocyte 241 
activation, OBs accumulate at the parasite plasma membrane in multiple foci prior to 242 
secreting their contents into the parasitophorous vacuole. In contrast, MOBs cluster 243 
together to form larger structures and then release their contents at only a few focal 244 
points (Olivieri et al., 2015). These different behaviors likely reflect specific 245 
mechanisms of vesicle discharge. 246 
In the search for novel potential drug target to block transmission, we analysed by 247 
proteomic analysis the proteins released by P. berghei gametes upon egress from the 248 
host cell. Between the proteins identified, we focused our attention on SUB1, a 249 
subtilisin-like serine protease known to be essential for egress of parasite asexual stages 250 
from the host cell (Yeoh et al., 2007). SUB1 subcellular localization, function and 251 
potential substrates in the sexual stages were unknown.  252 
We then characterized the expression profile and subcellular localization of SUB1 in 253 
P. berghei sexual stages. We showed that the protease is selectively expressed in mature 254 
male gametocytes and localizes to the secretory organelles involved in gamete egress, 255 
the osmiophilic bodies (Pace et al., 2019). We have investigated SUB1 function in the 256 
sexual stages by generating P. berghei transgenic lines deficient in SUB1 expression or 257 
enzyme activity in gametocytes and demonstrated that SUB1 plays an important role in 258 
male gamete egress (Pace et al., 2019). We also show for the first time that the SUB1 259 
substrate PbSERA3 is expressed in gametocytes and processed by SUB1 also in these 260 
stages, upon gametocyte activation (Pace et al., 2019). 261 
Taken together, our results strongly suggest that SUB1 is not only a promising drug 262 
target for asexual stages, but can also be considered an attractive malaria transmission- 263 
blocking target.  264 
 265 
Conclusions: 266 
This review aimed at elaborating on different aspects of three vector-borne parasitoses, 267 
babesiosis, leishmaniaisis and malaria, with a focus on the relationships between the 268 
parasites causing these diseases and their different vectors. 269 
We discussed the variety of Babesia spp. that infect dogs and represent a microcosm of 270 
the total variety of species which infect humans, domestic and wildlife animals. The 271 
similarities and differences between the diseases caused by piroplasmid agents in dogs 272 
and the precautions taken to prevent their transmission by blood transfusion can provide 273 
useful information also for human medicine.  274 
We also described a new group of Leishmania parasites recently discovered, forming 275 
the new subgenus Mundinia. These include both human pathogens and non-pathogenic 276 
species and raise interest because of their unusual insect vectors. 277 
Finally, we discussed some critical aspects of malaria transmission, with a specific 278 
focus on molecular mechanisms of P. berghei transmission to mosquito vectors.  279 
Information, education and public awareness are crucial elements in reducing the 280 
burden of vector-borne parasitoses. A lack of knowledge, both among patients and 281 
physicians, can increase transmission levels and lead to misdiagnosis and improper 282 
treatment. Therefore, a deep understanding of host-parasite interactions is essential to 283 
elucidate the complex dynamics of vector-borne parasite transmission. 284 
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